Testing effectiveness (Phase 2)Study completedNCT04667910
What this trial is testing
601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)
Who this might be right for
Central Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60